Detail-oriented individual with exceptional communication and project management skills. Proven ability to handle multiple tasks effectively and efficiently in fast-paced environments. Recognized for taking a proactive approach to identifying and addressing issues, with a focus on optimizing processes and supporting team objectives.
actively pursuing
Co-authorship: Cancer. 2011 Mar 15;117(6):1253-61. doi: 10.1002/cncr.25686. Epub 2010 Oct 19.
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
Co-authorship: http://meetinglibrary.asco.org/content/153497-156
A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
Co-authorship: Blood 2015 126:4221
A phase I/II trial of very low to low-dose continuous azacytidine in combination with standard doses of lenalidomide and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma.
Co-authorship: Blood 2020 Nov. https://doi.org/10.1182/blood-2020-139323
Cael-101 Is Well-Tolerated in AL Amyloidosis Patients Receiving Concomitant Cyclophosphamide-Bortezomib-Dexamethasone (CyborD): A Phase 2 Dose-Finding Study (NCT04304144)
Co-authorship: Blood 2020 Nov. https://doi.org/10.1182/blood-2020-140619
Outcomes in AL Amyloidosis: A Single Institution Experience
Co-authorship: Seminars in Hematology Dec. 2020 http://dx.doi.org/10.1053/j.seminhematol.2020.12.004
DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma
Co-authorship: American Journal of Cancer Research Sept. 2020 10(9):3047-3060
A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer
Co-authorship: Seminars of Hematology Dec. 2020 http://dx.doi.org/10.1053/j.seminhematol.2020.11.008
A Pilot Clinical Trial of Oral Tetrahydrouridine/Decitabine for Non-Cytotoxic Epigenetic Therapy of Chemo-resistant Lymphoid Malignancies
Co-authorship: https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e24118
A pilot study to determine the effects of early palliative care integration on patients with newly diagnosed multiple myeloma.